Regeneron Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) slid 1.08% to $652.02 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.57% to 4,155.38 and the Dow Jones Industrial Average rising 0.26% to 33,061.50. This was the stock's second consecutive day of losses. Regeneron Pharmaceuticals Inc. closed $95.40 short of its 52-week high ($747.42), which the company reached on April 8th.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) fell 1.01% to $178.64, Novartis AG ADR (NOVN.EB) fell 0.43% to $87.65, and Amgen Inc. (AMGN) fell 0.97% to $230.92. Trading volume (737,389) eclipsed its 50-day average volume of 639,882.
Data source: Dow Jones Market Data, FactSet. Data compiled May 2, 2022.
-MarketWatch Automation
(END) Dow Jones Newswires
May 02, 2022 17:19 ET (21:19 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.